INS and Hyperinsulinemia: Molecular alterations associated with the diabetic phenotype, such as abnormalities in insulin signaling, which results in insensitivity to insulin and subsequent hyperinsulinemia, may ultimately favor tumor development through the regulation of HIF-1α, increased glucose uptake, and its utilization.